Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Coronary Disease

3,4-methylenedioxyamphetamine has been researched along with Coronary Disease in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goble, AJ1
Fontana, AF1
Kerns, RD1
Blatt, SJ1
Rosenberg, RL1
Burg, MM1
Colonese, KL1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Coronary Disease

ArticleYear
Do caring wives protect against cardiac disease?
    The Medical journal of Australia, 1989, Aug-21, Volume: 151, Issue:4

    Topics: Australia; Coronary Disease; Female; Humans; Life Style; Love; Male; Marriage; Single Person

1989
Cynical Mistrust and the search for self-worth.
    Journal of psychosomatic research, 1989, Volume: 33, Issue:4

    Topics: Adult; Competitive Behavior; Coronary Disease; Dependency, Psychological; Hostility; Humans; Love; M

1989